BIODEXA PHARMACEUTICALS-ADR (BDRX) Stock Income Statement
USA - NASDAQ:BDRX - US59564R8806 - ADR
6.63 USD
-0.07 (-1.04%)
6.7743 USD
+0.14 (+2.18%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 381.00K | 699.00K | 578.00K | |||
| Operating Expenses | 8.99M | 9.20M | 8.39M | 9.63M | 7.58M | |||
| Research and Development | 4.91M | 5.44M | 4.07M | 5.11M | 4.65M | |||
| Selling, General, and Administrative Expenses | 4.14M | 3.79M | 4.34M | 4.54M | 2.95M | |||
| Operating Income | -8.99M | -9.20M | -8.01M | -8.93M | -7.00M | |||
| Interest Income/Expense | 2.67M | 3.36M | 519.00K | 444.00K | 892.00K | |||
| Other Income/Expense | -190.00K | -143.00K | 10.00K | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Income Before Taxes | -6.52M | -5.98M | -7.49M | -8.49M | -6.11M | |||
| Income Tax | -290.00K | -250.00K | -406.00K | -832.00K | -646.00K | |||
| Net Income | -6.23M | -5.73M | -7.08M | -7.66M | -5.46M | |||
| EBITDA | -8.73M | -8.95M | -7.73M | -8.59M | -6.59M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -21.21 | -47.31 | -914.03 | -63.19K | -111.35M | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | -1858.01% | -1095.28% | -944.64% | |||
| Operating Profit Margin | N/A | N/A | -2103.41% | -1277.83% | -1210.73% | |||
All data in GBP